[1] |
Ju C,Li X,Gadani S,et al. Portal Vein Thrombosis: Diagnosis and Endovascular Management[J]. Rofo, 2022, 194(2): 169-180.
|
[2] |
Prakash S,Bies J,Hassan M,et al. Portal vein thrombosis in cirrhosis: A literature review[J]. Front Med(Lausanne), 2023, 10: 1134801.
|
[3] |
Ginès P,Krag A,Abraldes JG,et al. Liver cirrhosis[J]. Lancet, 2021, 398(10308): 1359-1376.
|
[4] |
尹修才,王辉. 腹腔镜巨脾切除治疗肝硬化门静脉高压的效果观察[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(03): 314-317.
|
[5] |
Pan J,Wang L,Gao F,et al. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis[J]. Eur J Intern Med, 2022, 104: 21-32.
|
[6] |
Weinberg EM,Palecki J,Reddy KR. Direct-Acting Oral Anticoagulants(DOACs)in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis[J]. Semin Liver Dis,2019, 39(2): 195-208.
|
[7] |
Huang X,Fan X,Zhang R,et al. Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices[J]. Eur J Gastroenterol Hepatol, 2020, 32(3): 401-405.
|
[8] |
贾守洪,鲁旭,彭彬. 多措施联合的腹腔镜肝切除术治疗肝癌合并肝硬化并门静脉高压症的临床应用研究[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(06): 569-572.
|
[9] |
Soto A,Guillén-Grima F,Morales G,et al. Prevalence and incidence of ictus in Europe: systematic review and meta-analysis[J]. An Sist Sanit Navar, 2022, 45(1): e0979.
|
[10] |
Abdel-Razik A,Mousa N,Elhelaly R,et al. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system[J]. Eur J Gastroenterol Hepatol, 2015, 27(5): 585-592.
|
[11] |
Chen H,Trilok G,Wang F,et al. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics &risk factors[J]. Indian J Med Res, 2014, 139(2): 260-266.
|
[12] |
方翔,李敏. 肝硬化门静脉血栓形成的危险因素分析[J]. 安徽医学, 2018, 39(05): 595-598.
|
[13] |
李玲,陆申新,崔春晓,等. 591例肝硬化患者门静脉血栓形成的危险因素分析[J]. 复旦学报(医学版), 2017, 44(03): 288-293.
|
[14] |
李雅萍. 血浆D-二聚体和蛋白S检测在肝硬化疾病门静脉血栓形成中的应用[J]. 浙江临床医学, 2015, 23(08): 1334-1335.
|
[15] |
Lin GS,Xu Q,Zhao SY,et al. Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors[J]. Zhonghua Gan Zang Bing Za Zhi, 2016, 24(7): 513-517.
|
[16] |
刘金芝,胡乃中,许建明. 肝硬化合并门静脉血栓形成危险因素及预后研究[J]. 安徽医科大学学报, 2016, 51(02): 280-283.
|
[17] |
吕笑娟,孙亚星,冯永星,等. 肝硬化合并门静脉血栓形成的危险因素分析[J]. 胃肠病学和肝病学杂志, 2018, 27(04): 406-408.
|
[18] |
田颖,陈文明,张冬磊,等. 肝硬化患者门静脉血栓形成的多因素分析[J]. 中国医师进修杂志, 2012, 35(22): 21-24.
|
[19] |
熊静平,刘海英,张跃新. 肝硬化合并门静脉血栓形成的相关危险因素分析[J]. 肝脏, 2018, 23(03): 206-209.
|
[20] |
熊雪丽. 肝硬化合并门静脉血栓的危险因素及PLT、DD对其形成的预测价值[J]. 分子诊断与治疗杂志, 2022, 14(08): 1271-1274.
|
[21] |
杨宁,张冬磊. 肝硬化门静脉血栓形成患者凝血和纤溶系统变化的临床研究[J]. 中国医师进修杂志, 2009, 32(07): 11-13.
|
[22] |
杨其源,罗铎,沈波,等. 肝硬化门静脉血栓形成危险因素分析[J]. 广州医科大学学报, 2017, 45(05): 18-21.
|
[23] |
Zhang D,Hao J,Yang N. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis[J]. J Gastroenterol Hepatol, 2010, 25(1): 116-121.
|
[24] |
张冬磊,杨宁. 肝硬化患者门静脉血栓形成的相关危险因素[J]. 世界华人消化杂志, 2008, 16(27): 3106-3109.
|
[25] |
张莉,王龙,杨根妹. 肝硬化门静脉血栓形成的相关危险因素分析[J]. 中华消化杂志, 2014, 34(02): 100-104.
|
[26] |
郑盛,严晓会,刘海,等. 肝硬化患者门静脉血栓形成危险因素的Logistic回归分析[J]. 肝脏, 2009, 14(06): 446-448.
|
[27] |
Benmassaoud A,AlRubaiy L,Yu D,et al. A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia[J]. Aliment Pharmacol Ther, 2019, 50(9): 1049-1058.
|
[28] |
Jiang S,Ai Y,Ni L,et al. Platelet-derived TGF-β1 is related to portal vein thrombosis in cirrhosis by promoting hypercoagulability and endothelial dysfunction[J]. Front Cardiovasc Med, 2022, 9: 938397.
|
[29] |
Garg A,Singh K,Bhardwaj N,et al. Correlation of Portal Vein Diameter as a Reflection of Portal Hypertension With Clinical and Laboratory Parameters in Chronic Liver Disease[J]. J Assoc Physicians India, 2022, 70(4): 11-12.
|
[30] |
Zocco Ma,Di Stasio E,De Cristofaro R,et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol, 2009, 51(4): 682-689.
|